PARAMETRIC PORTFOLIO ASSOCIATES LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q1 2022$15,389,000
+4.5%
394,985
+6.8%
0.01%0.0%
Q4 2021$14,732,000
+29.1%
369,679
+17.1%
0.01%
+33.3%
Q3 2021$11,408,000
+16.2%
315,648
+31.8%
0.01%0.0%
Q2 2021$9,818,000
+22.6%
239,517
+30.4%
0.01%
+20.0%
Q1 2021$8,010,000
-10.1%
183,628
+3.1%
0.01%
-16.7%
Q4 2020$8,911,000
+967.2%
178,050
+797.5%
0.01%
+500.0%
Q3 2020$835,00019,8390.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders